All COVID-19 – Page 12 – BIDMC’s COVID-19 Initiatives

3 feet, or 6? Study of Massachusetts schools finds reduced spacing between students can be safe in class

Researchers, including physicians from BIDMC, collected information from hundreds of Massachusetts school districts over 16 weeks to examine whether COVID-19 is more likely to be transmitted if students are seated closely together. The team found no substantial difference in the number of cases of COVID-19 among either students or staff in school districts that implemented a distancing policy of three feet versus six feet between students.

As Massachusetts prepares for final phase of reopening, businesses warn recovery ‘is not going to be flicking a switch’

As Massachusetts prepares for final phase of reopening, businesses warn recovery 'is not going to be flicking a switch'

How approval of Johnson & Johnson’s ‘one and done’ COVID-19 vaccine could change Canada’s vaccination game

How approval of Johnson & Johnson's 'one and done' COVID-19 vaccine could change Canada's vaccination game

Mass. Residents find other paths to secure COVID-19 vaccine appointments

Mass. Residents find other paths to secure COVID-19 vaccine appointments

Transcript: The Path Forward: Vaccines with Johnson & Johnson CEO Alex Gorsky

Transcript: The Path Forward: Vaccines with Johnson & Johnson CEO Alex Gorsky

A year into Covid, top health execs keep rivalry on the sidelines

A year into Covid, top health execs keep rivalry on the sidelines

Kevin Hill, MD (Addiction Psychiatry, BIDMC) and Mia Hazel, MD (Addiction Psychiatry BIDMC), shared data showing those with addictions are eight times more likely than those without to get COVID-19. They have found that increasing the frequency of virtual appointments has been essential for helping patients stay engaged in recovery treatment.

How The Pandemic Has Made Staying Sober Even More Difficult

Dan Barouch, MD, PhD (Center for Virology and Vaccine Research, BIDMC) spoke to recently emerged data from the Johnson & Johnson trial where researchers looked for signs of infection in 3,000 participants up to 71 days after getting the single-dose vaccine. Risk of infection in that study seemed to fall by about 74 percent.

Plan to Ditch the Mask After Vaccination? Not So Fast.

Pharmaceutical giant Merck will help manufacture the newly authorized Johnson & Johnson single-shot COVID-19 vaccine. Dan Barouch, MD, PhD (Center for Virology and Vaccine Research, BIDMC) shared that the collaboration could greatly accelerate the rollout of the Johnson & Johnson vaccine at a time when acceleration of the vaccine campaign in the US and throughout the world is needed.

Merck to help rival Johnson & Johnson make COVID-19 vaccine.

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44